← Back to Search

Shared Decision Making for Chronic Kidney Disease (DIAL-SDM Trial)

N/A

Waitlist Available

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 12 months

Awards & highlights

DIAL-SDM Trial Summary

This trial is testing a dialysis shared decision-making (DIAL-SDM) intervention for nephrologists and their patients ≥65 years old with an estimated glomerular filtration rate (eGFR) of ≤ 20 ml/min/ /1.73 m2. The intervention includes communication training and coaching sessions for patients (and caregivers, if available) to explore each patient's relevant contextual information (values, preferences, and goals), and help them identify and practice important questions for their nephrologist. The study outcomes will be assessed during two nephrology office visits and at 6 months.

Who is the study for?

This trial is for patients aged 65 or older with advanced chronic kidney disease (stages 4 or 5) who haven't yet decided on dialysis and speak English. Their nephrologist must be part of the study and working at Strong Memorial Hospital. Caregivers involved in patient care can also participate.Check my eligibility

What is being tested?

The trial tests a shared decision-making program (DIAL-SDM) against usual care for kidney disease treatment choices. Nephrologists will get communication training, while patients receive coaching to help them discuss their treatment preferences effectively.See study design

What are the potential side effects?

Since this intervention involves education and communication rather than medication, there are no direct medical side effects; however, participants may experience emotional or psychological impacts from discussing sensitive health decisions.

DIAL-SDM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

acceptability of DIAL-SDM intervention

feasibility of DIAL-SDM intervention

Interventional procedure

DIAL-SDM Trial Design

2Treatment groups

Experimental Treatment

Group I: interventionExperimental Treatment1 Intervention

Group II: controlExperimental Treatment1 Intervention

Usual care

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor

841 Previous Clinical Trials

533,657 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,705 Previous Clinical Trials

7,507,226 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,364 Previous Clinical Trials

4,315,342 Total Patients Enrolled

Media Library

DIAL-SDM Clinical Trial Eligibility Overview. Trial Name: NCT04392440 — N/A

Chronic Kidney Disease Research Study Groups: intervention, control

Chronic Kidney Disease Clinical Trial 2023: DIAL-SDM Highlights & Side Effects. Trial Name: NCT04392440 — N/A

DIAL-SDM 2023 Treatment Timeline for Medical Study. Trial Name: NCT04392440 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people have enrolled in the experiment so far?

"Yes, the data hosted on clinicaltrials.gov attests to this medical trial's active recruitment efforts. This experiment was initially posted February 28th 2022 and has been updated as recently as March 28th of this year; it is intended to include 60 participants at a single site."

Answered by AI

Are there any opportunities still available to join this research endeavor?

"Clinicaltrials.gov provides evidence that this trial is actively recruiting subjects, having been posted on February 28th 2022 and updated only recently, on March 28th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Shared Decision Making in Dialysis

Fahad Saeed 2022. "Shared Decision Making in Dialysis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04392440.

All > Dialysis